E2D(R1) Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 13, 2024
March 14, 2024
d300a747-e4a5-431a-aeb4-03dd8f84a959
Related Documents
Competitive Generic Therapies
Guidance DocumentOctober 5, 2022Center for Drug Evaluation and Research
Controlled Correspondence Related to Generic Drug Development
Guidance DocumentMarch 18, 2024Center for Drug Evaluation and Research
Electronic Submission of Expedited Safety Reports From IND-Exempt BA/BE Studies Guidance for Industry
Guidance DocumentApril 1, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox